Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: We turned a profit!
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Net income for the last quarter is $1,192,695 (compared to a loss of $1,004,482 in 2011).

Not really big, but much better than last year (where we got $45,000):

"During the three ... months ended November 30, 2012, PDS entered into licensing agreements with third parties, pursuant to which PDS received aggregate proceeds of $4,370,000 ...."

11 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply